BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23689508)

  • 1. Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    J Biol Chem; 2013 Jul; 288(27):19739-49. PubMed ID: 23689508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation.
    Cotter DG; Schugar RC; Wentz AE; d'Avignon DA; Crawford PA
    Am J Physiol Endocrinol Metab; 2013 Feb; 304(4):E363-74. PubMed ID: 23233542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E176-85. PubMed ID: 24865983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obligate role for ketone body oxidation in neonatal metabolic homeostasis.
    Cotter DG; d'Avignon DA; Wentz AE; Weber ML; Crawford PA
    J Biol Chem; 2011 Mar; 286(9):6902-10. PubMed ID: 21209089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice.
    Burgess SC; Leone TC; Wende AR; Croce MA; Chen Z; Sherry AD; Malloy CR; Finck BN
    J Biol Chem; 2006 Jul; 281(28):19000-8. PubMed ID: 16670093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished ketone interconversion, hepatic TCA cycle flux, and glucose production in D-β-hydroxybutyrate dehydrogenase hepatocyte-deficient mice.
    Stagg DB; Gillingham JR; Nelson AB; Lengfeld JE; d'Avignon DA; Puchalska P; Crawford PA
    Mol Metab; 2021 Nov; 53():101269. PubMed ID: 34116232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic adaptations to change of nutrition at birth.
    Girard J
    Biol Neonate; 1990; 58 Suppl 1():3-15. PubMed ID: 2265217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.
    Cotter DG; Ercal B; Huang X; Leid JM; d'Avignon DA; Graham MJ; Dietzen DJ; Brunt EM; Patti GJ; Crawford PA
    J Clin Invest; 2014 Dec; 124(12):5175-90. PubMed ID: 25347470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective muscle ketone body oxidation disrupts BCAA catabolism by altering mitochondrial branched-chain aminotransferase.
    Mechchate H; Abdualkader AM; Bernacchi JB; Gopal K; Tabatabaei Dakhili SA; Yang K; Greenwell AA; Kong X; Crawford PA; Al Batran R
    Am J Physiol Endocrinol Metab; 2023 May; 324(5):E425-E436. PubMed ID: 36989424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase.
    Burgess SC; Hausler N; Merritt M; Jeffrey FM; Storey C; Milde A; Koshy S; Lindner J; Magnuson MA; Malloy CR; Sherry AD
    J Biol Chem; 2004 Nov; 279(47):48941-9. PubMed ID: 15347677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism.
    Yubero P; Hondares E; Carmona MC; Rossell M; Gonzalez FJ; Iglesias R; Giralt M; Villarroya F
    Endocrinology; 2004 Sep; 145(9):4268-77. PubMed ID: 15178647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment.
    Wentz AE; d'Avignon DA; Weber ML; Cotter DG; Doherty JM; Kerns R; Nagarajan R; Reddy N; Sambandam N; Crawford PA
    J Biol Chem; 2010 Aug; 285(32):24447-56. PubMed ID: 20529848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.
    Potthoff MJ; Inagaki T; Satapati S; Ding X; He T; Goetz R; Mohammadi M; Finck BN; Mangelsdorf DJ; Kliewer SA; Burgess SC
    Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10853-8. PubMed ID: 19541642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver.
    Haase TN; Ringholm S; Leick L; Biensø RS; Kiilerich K; Johansen S; Nielsen MM; Wojtaszewski JF; Hidalgo J; Pedersen PA; Pilegaard H
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1501-9. PubMed ID: 21832205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway.
    Potthoff MJ; Boney-Montoya J; Choi M; He T; Sunny NE; Satapati S; Suino-Powell K; Xu HE; Gerard RD; Finck BN; Burgess SC; Mangelsdorf DJ; Kliewer SA
    Cell Metab; 2011 Jun; 13(6):729-38. PubMed ID: 21641554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shc proteins influence the activities of enzymes involved in fatty acid oxidation and ketogenesis.
    Hagopian K; Tomilov AA; Tomilova N; Kim K; Taylor SL; Lam AK; Cortopassi GA; McDonald RB; Ramsey JJ
    Metabolism; 2012 Dec; 61(12):1703-13. PubMed ID: 22683097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of hepatic phosphoenolpyruvate carboxykinase 1 dysregulates metabolic responses to acute exercise but enhances adaptations to exercise training in mice.
    Rome FI; Shobert GL; Voigt WC; Stagg DB; Puchalska P; Burgess SC; Crawford PA; Hughey CC
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E9-E23. PubMed ID: 36351254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.
    Fletcher JA; Deja S; Satapati S; Fu X; Burgess SC; Browning JD
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31012869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo.
    Fisher FM; Estall JL; Adams AC; Antonellis PJ; Bina HA; Flier JS; Kharitonenkov A; Spiegelman BM; Maratos-Flier E
    Endocrinology; 2011 Aug; 152(8):2996-3004. PubMed ID: 21712364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholinesterase Inhibitor Donepezil Effects on Plasma β-Hydroxybutyrate Levels in the Treatment of Alzheimer's Disease.
    Wan L; Lu J; Fu J; Huang J; Yang Q; Xin B; Chen L; Huo Y; Zhong Y; Guo C
    Curr Alzheimer Res; 2018; 15(10):917-927. PubMed ID: 29852870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.